03.30.17
William “Bill” Hirschman has joined the leadership team of Worldwide Clinical Trials as executive vice president and head of global business development. Mr. Hirschman will lead Worldwide’s growing business development organization, a large global team that includes sales, sales operations, and proposal development.
“At the heart of our strong and successful growth trajectory here at Worldwide is our business development team,” said Peter Benton, president and chief operating officer at Worldwide. “We selected Bill to join our leadership team because he has a proven track record of driving significant growth, while also possessing the right combination of industry expertise and experience, with the strategic mind-set to bring it all together. We’re delighted that Bill will be helping us write the next chapter in Worldwide’s story of continued success.”
Mr. Hirschman has 25 years of experience in a range of leadership roles within CROs, pharmaceutical and scientific companies. Most recently, he served as global vice president of commercial operations at Fisher Clinical Services, a company specializing in providing clinical trial supplies and logistics to the pharma and biopharma industries. Prior to Fisher, he managed sales, marketing and business development for the Clinical Pharmacology Phase I, Clinical Phase II-III and Interactive Voice Response (IVR) business units of Covance.
“At the heart of our strong and successful growth trajectory here at Worldwide is our business development team,” said Peter Benton, president and chief operating officer at Worldwide. “We selected Bill to join our leadership team because he has a proven track record of driving significant growth, while also possessing the right combination of industry expertise and experience, with the strategic mind-set to bring it all together. We’re delighted that Bill will be helping us write the next chapter in Worldwide’s story of continued success.”
Mr. Hirschman has 25 years of experience in a range of leadership roles within CROs, pharmaceutical and scientific companies. Most recently, he served as global vice president of commercial operations at Fisher Clinical Services, a company specializing in providing clinical trial supplies and logistics to the pharma and biopharma industries. Prior to Fisher, he managed sales, marketing and business development for the Clinical Pharmacology Phase I, Clinical Phase II-III and Interactive Voice Response (IVR) business units of Covance.
